R.M.Sincerbeaux Capital Management LLC Abbott Laboratories Transaction History

R.M.Sincerbeaux Capital Management LLC

$157 Million
Q1 2024

A detailed history of R.M.Sincerbeaux Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, R.M.Sincerbeaux Capital Management LLC holds 12,500 shares of ABT stock, worth $1.32 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

12,500

Previous 12,816 2.47%

Holding current value

$1.32 Million

Previous $1.41 Million 0.71%

% of portfolio

0.91%

Previous 1.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $34,608 - $38,223	-316 Reduced 2.47%	12,500 $1.42 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $61,689 - $75,513	-684 Reduced 5.07%	12,816 $1.41 Million
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $24,215 - $28,502	-250 Reduced 1.82%	13,500 $1.37 Million
Q2 2022 Aug 02, 2022	SELL	$102.07 - $123.37 $20,414 - $24,674	-200 Reduced 1.43%	13,750 $1.49 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $46,664 - $51,624	-400 Reduced 2.79%	13,950 $1.65 Million

Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $957,124 - $1.23 Million	-12,500 Reduced 46.55%	14,350 $1.31 Million
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $23,553 - $26,220	-300 Reduced 1.1%	26,850 $2.33 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $24,552 - $26,622	300 Added 1.12%	27,150 $2.27 Million
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $21,864 - $25,500	-300 Reduced 1.1%	26,850 $0
Q2 2018 Jul 31, 2018	BUY	$57.57 - $63.54 $17,271 - $19,062	300 Added 1.12%	27,150 $1.66 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $100,926 - $112,644	-2,100 Reduced 7.25%	26,850 $1.43 Million
Q2 2017 Aug 10, 2017	BUY	N/A	28,950	28,950 $1.41 Million

Others Institutions Holding ABT

# of Institutions

3,109

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $184B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of R.M.Sincerbeaux Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on R.M.Sincerbeaux Capital Management LLC with notifications on news.

Account

R.M.Sincerbeaux Capital Management LLC Abbott Laboratories Transaction History